$RLFTF $NRXP (opinion) Post by OU on Yh0 - The new

$RLFTF $NRXP (opinion) Post by OU on Yh0 - The news from Biophore is tremendous. It validates the efficacy of not the infused version but the INHALED version of Aviptadil. Think about this for a minute. If the inhaler actually works (which is implied by Biophore jumping to EUA) then we can now conclude we have a treatment that can be distributed widely and used for in home treatments. Folks, this could mean all the dreams of multi-billion dollar valuations are a reality, translating to many dollars per share in stock price ($8-$12 is not out of the question for RLFTF). Why such a valuation? Because a successful inhaled version of Aviptadil that is stable and effective is the equivalent of penicillin for the lungs, which the world desperately needs not just for Covid, but for many other lung indications. I will be buying more with this news and at these ridiculously low prices.

Furthermore, how does the FDA ignore this request for EUA in the US now? If India approves and it’s successful, then the US will need to seriously consider the drug. Note that the US EUA is for IV version not inhaled, and we still showed results. FDA cannot ignore this drug for much longer and not appear biased. Thank you Biophore!

This is an amazing buying opportunity.

Go INHALED Aviptadil

OU

$MJ